
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Correction
JAMA. 2003;289:178.
Incorrect Data in Table. In the Original Contribution entitled "Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)" published in the December 18, 2002, issue of THE JOURNAL (2002;288:2981-2997), there were incorrect data in Table 6. This Table 6 replaces the one on page 2992. The new data do not affect the results or conclusions of the original article.
|
|
|
|
Table 6. Causes of Death by Antihypertensive Treatment Group
|
|
|
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
ALLHAT: What has it taught us so far?
Leenen
CMAJ 2004;171:719-720.
FULL TEXT
|